Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
UCLA Depression Research and Clinic Program
mi
from
Los Angeles, CA
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
UCLA Depression Research and Clinic Program
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Hartford Hospital- The Institute of Living
mi
from
Hartford, CT
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Hartford Hospital- The Institute of Living
mi
from
Hartford, CT
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
TMS Specialists Chicago
mi
from
Chicago, IL
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
TMS Specialists Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Sheppard Pratt Health System
mi
from
Baltimore, MD
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Sheppard Pratt Health System
mi
from
Baltimore, MD
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Center for Mood Disorders and Neuromodulation Therapies, UMDNJ-SOM
mi
from
Cherry Hill, NJ
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Center for Mood Disorders and Neuromodulation Therapies, UMDNJ-SOM
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Duke University Brain Stimulation and Neurophysiology Center
mi
from
Durham, NC
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Duke University Brain Stimulation and Neurophysiology Center
mi
from
Durham, NC
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Mood Disorders Treatment Research Program University of Pittsburgh-Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Mood Disorders Treatment Research Program University of Pittsburgh-Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Butler Hospital Mood Disorders Research Program, Brown Department of Psychiatry and Human Behavior
mi
from
Providence, RI
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Butler Hospital Mood Disorders Research Program, Brown Department of Psychiatry and Human Behavior
mi
from
Providence, RI
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
MUSC Institute of Psychiatry, Brain Stimulation Lab
mi
from
Charleston, SC
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
MUSC Institute of Psychiatry, Brain Stimulation Lab
mi
from
Charleston, SC
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
R/D Clinical Research, Inc.
mi
from
Lake Jackson, TX
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
R/D Clinical Research, Inc.
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
UCSD Medical Center
mi
from
San Diego, CA
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
UCSD Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
UCLA Harbor
mi
from
Torrance, CA
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
UCLA Harbor
mi
from
Torrance, CA
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated:  10/5/2015
Wake Forest University Medical Center
mi
from
Winston Salem, NC
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Status: Enrolling
Updated: 10/5/2015
Wake Forest University Medical Center
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Complex Dynamic Systems in Mood Disorders
Complex Dynamic Systems in Mood Disorders
Status: Enrolling
Updated:  10/5/2015
Bipolar Clinic and Research Program at Massachusetts General Hospital
mi
from
Boston, MA
Complex Dynamic Systems in Mood Disorders
Complex Dynamic Systems in Mood Disorders
Status: Enrolling
Updated: 10/5/2015
Bipolar Clinic and Research Program at Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Pacific Clinical Research Medical Group
mi
from
Arcadia, CA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Pacific Clinical Research Medical Group
mi
from
Arcadia, CA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
California Neuroscience Research Medical Group, Inc
mi
from
Sherman Oaks, CA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
California Neuroscience Research Medical Group, Inc
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Gulfcoast Clinical Research Center
mi
from
Fort Myers, FL
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Gulfcoast Clinical Research Center
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Clinical Neurosciences Solutions
mi
from
Orlando, FL
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Clinical Neurosciences Solutions
mi
from
Orlando, FL
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Stedman Clinical Trials
mi
from
Tampa, FL
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Stedman Clinical Trials
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Carman Research
mi
from
Smyrna, GA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Carman Research
mi
from
Smyrna, GA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Pharmasite Research
mi
from
Baltimore, MD
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Pharmasite Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Clinical Insights Inc
mi
from
Glen Burnie, MD
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Clinical Insights Inc
mi
from
Glen Burnie, MD
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Brooklyn Medical Institute
mi
from
Brooklyn, NY
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Brooklyn Medical Institute
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Medical & Behavioral Health Research
mi
from
New York, NY
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Medical & Behavioral Health Research
mi
from
New York, NY
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
The Medical Research Network, LLC
mi
from
New York, NY
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
The Medical Research Network, LLC
mi
from
New York, NY
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Finger Lakes Clinical Research
mi
from
Rochester, NY
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Midwest Clinical Research Center
mi
from
Dayton, OH
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Oregon Center for Clinical Investigations, Inc.
mi
from
Portland, OR
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Oregon Center for Clinical Investigations, Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Oregon Center for Clinical Investigations, Inc
mi
from
Salem, OR
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Oregon Center for Clinical Investigations, Inc
mi
from
Salem, OR
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Carolina Clinical Research Services
mi
from
Columbia, SC
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Carolina Clinical Research Services
mi
from
Columbia, SC
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
FutureSearch Trials of Dallas
mi
from
Dallas, TX
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
FutureSearch Trials of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Bayou City Research, Ltd.
mi
from
Houston, TX
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Bayou City Research, Ltd.
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Radiant Research, Inc.
mi
from
Murray, UT
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Radiant Research, Inc.
mi
from
Murray, UT
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Psychiatric Alliance of The Blue Ridge
mi
from
Charlottesville, VA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Psychiatric Alliance of The Blue Ridge
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
NeuroScience, Inc.
mi
from
Herndon, VA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Northwest Clinical Research Center
mi
from
Bellevue, WA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Summit Research Network LLC
mi
from
Seattle, WA
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Summit Research Network LLC
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  10/6/2015
Northbrooke Research Center
mi
from
Brown Deer, WI
Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 10/6/2015
Northbrooke Research Center
mi
from
Brown Deer, WI
Click here to add this to my saved trials